LJ

Leslie S. Johnson

MA Macrogenics: 8 patents #1 of 28Top 4%
BO BOE: 1 patents #1,433 of 2,957Top 50%
Overall (2023): #9,925 of 537,848Top 2%
9
Patents 2023

Issued Patents 2023

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
11840571 Methods of using bispecific molecules having immunoreactivity with PD-1 and CTLA-4 Gurunadh Reddy Chichili, Kalpana Shah, Ross La Motte-Mohs, Paul A. Moore, Ezio Bonvini +1 more 2023-12-12
11820818 Multi-chain polypeptide-containing tri-specific binding molecules Ling Huang, Gurunadh Reddy Chichili, Kalpana Shah, Chia-Ying Kao Lam, Stephen James Burke +4 more 2023-11-21
11795226 Bispecific CD16-binding molecules and their use in the treatment of disease Gundo Diedrich, Liqin Liu, Hua Li 2023-10-24
11697684 Tri-specific binding molecules that specifically bind to multiple cancer antigens Ezio Bonvini, Paul A. Moore, Jonathan Li, Kalpana Shah 2023-07-11
11685781 Variant CD3-binding domains and their use in combination therapies for the treatment of disease Ezio Bonvini, Ling Huang, Chia-Ying Kao Lam, Gurunadh Reddy Chichili, Ralph Alderson +1 more 2023-06-27
11680096 Compound targeting IL-23A and TNF-alpha and uses thereof Rachel Rebecca Barrett, Sanjaya Singh, Kathleen Last-Barney, Daw-Tsun Shih, Patricia Giblin +2 more 2023-06-20
11639386 Bi-specific monovalent diabodies that are capable of binding CD19 and CD3, and uses thereof Ezio Bonvini, Chia-Ying Kao Lam, Paul A. Moore, Liqin Liu, Scott Koenig 2023-05-02
11623959 PD-1-binding molecules and methods of use thereof Kalpana Shah, Douglas H. Smith, Ross La Motte-Mohs, Paul A. Moore, Ezio Bonvini +1 more 2023-04-11
11591400 B7-H3 directed antibody drug conjugates Deryk T. Loo, Ling Huang, Thomas Son, Juniper A. Scribner, Ezio Bonvini 2023-02-28